Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  PEG-interleukin-2
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase III Study of IL-2 vs IL-2 plus PEG-IL-2 in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-85C, NCI-T90-0053N, T90-0053
Phase I/II Study of Intratumoral PEG-IL-2 in Patients with Clinical Stage B2/C Prostate Cancer Undergoing Radical Prostatectomy (Summary Last Modified 07/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-HSPC-9402069, NCI-V94-0537
Phase II Study of PEG-IL-2 in Patients with Advanced Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UNM-0989C, NCI-V89-0215
Phase I Study of Polyethylene Glycol-Modified Recombinant Human Interleukin-2 in Patients with Metastatic Cancer (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-89-C-131B, NCI-T89-0085N, T89-0085
Phase I Study of PEG-IL-2 in Patients with Cytogenetic or Clinical Relapse of CML Following Allogeneic Marrow Transplantation (Summary Last Modified 08/90)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor:
Protocol IDs: MSKCC-90022, NCI-V90-0072
Start Over